Any release of treated water into the Pacific will be done in small quantities each time and carried out over a period of about 30 years.
For Osamu Tsukimori's latest contributions to The Japan Times, see below:
Vaccines targeting new variants of the coronavirus won't require domestic clinical trials if the production process and handling of the shots are similar to those of the original.
The prime minister is likely to call a Cabinet meeting on the fate of the water next Tuesday, local reports say, after meeting with national fisheries association chief.
Even if 70,000 vaccinations per day were given to Tokyoites, the capital could still see a fourth wave of infections peaking at 1,610 new cases on May 14, the study showed.
Most say a full economic recovery is unlikely until well after the vaccination of the general public is underway.
Concerns over Japan’s national security have arisen because of the obligations of a Chinese affiliate under that country's National Intelligence Law.
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.
With domestically developed vaccines some way off and regular inoculations a possibility, Japan may need to look to Russia and China to secure enough shots.
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
Those in the industry worry that draining the water from the nuclear plant into the sea would hinder the recovery they have made in the years since the disaster.